Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review.
Compounds derived from biologic sources, or biologicals, are increasingly utilized as therapeutic agents in malignancy. Development of anti-cancer targeted therapies from biologics is increasingly being utilized. Cetuximab, a chimeric monoclonal antibody, is one such anti-cancer targeted therapeutic that has shown efficacy in quelling the rate of patient decline in colorectal, head/neck, and non-small cell lung cancer. However, due to the relatively recent addition of biologic compounds to the therapeutic arsenal, information related to adverse reactions is less well known than those seen in traditional chemotherapeutics. Dermatologic reactions have been demonstrated as the most frequent side effect cited during cetuximab therapy for malignancy; however, other effects may lead to greater morbidity. In general, pulmonary complications of therapeutics can lead to significant morbidity and mortality. The purpose of this review is to compile the various pulmonary side effects seen in patients treated with cetuximab for various malignancies, and to compare the incidence of these adverse reactions to standard therapies.
Hoag
Jeffrey B
JB
Cancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia, PA, USA. jhoag@drexelmed.edu
Azizi
Aimel
A
Doherty
Timothy J
TJ
Lu
Jason
J
Willis
Rudolph E
RE
Lund
Mark E
ME
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068818:Cetuximab; D006801:Humans; D008168:Lung / Q000187:drug effects* / Q000473:pathology; D009369:Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab
Expert Opin Drug Saf. 2007 Mar;6(2):175-82
17367263
J Clin Oncol. 2005 Dec 1;23(34):8786-93
16246975
J Clin Oncol. 2007 Jun 1;25(16):2171-7
17538161
J Clin Oncol. 2008 May 10;26(14):2311-9
18390971
N Engl J Med. 2008 Sep 11;359(11):1116-27
18784101
J Clin Oncol. 2001 Jul 1;19(13):3234-43
11432891
J Clin Oncol. 2005 Aug 20;23(24):5568-77
16009950
Br J Cancer. 2008 Aug 5;99(3):455-8
18665167
J Korean Med Sci. 2007 Sep;22 Suppl:S98-S103
17923763
J Clin Oncol. 2005 Dec 1;23(34):8646-54
16314626
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):391-5
17980508
Ann Oncol. 2007 Feb;18(2):305-10
17079693
Int J Biol Markers. 2007 Jan-Mar;22(1 Suppl 4):S53-61
17520582
Oncology (Williston Park). 2006 Oct;20(11):1373-82; discussion 1382, 1392-4, 1397
17112000
J Clin Oncol. 2004 Apr 1;22(7):1201-8
14993230
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1384-90
16979839
Indian J Cancer. 2007 Apr-Jun;44(2):56-61
17938482
J Clin Oncol. 2004 Jul 1;22(13):2610-6
15226328
J Clin Oncol. 2005 Aug 20;23(24):5578-87
16009949
N Engl J Med. 2007 Nov 15;357(20):2040-8
18003960
Clin Colorectal Cancer. 2008 Jul;7(4):273-9
18650196
Ann Oncol. 2007 Apr;18(4):738-44
17208931
J Clin Oncol. 2005 Dec 20;23(36):9089-96
16301597
Ann Oncol. 2008 Aug;19(8):1442-1449
18441330
JAMA. 2008 Oct 22;300(16):1887-96
18940975
Gynecol Oncol. 2008 Aug;110(2):140-5
18554700
Ann Oncol. 2008 Apr;19(4):734-8
18272912
Nat Biotechnol. 2006 Jul;24(7):769-76
16841057
Cancer. 2008 Jun 15;112(12):2733-9
18412149
Clin Cancer Res. 2001 May;7(5):1204-13
11350885
Ann Oncol. 2008 Apr;19(4):711-6
18073221
Ann Oncol. 2007 Mar;18(3):510-7
17164226
Cancer. 2008 Nov 1;113(9):2512-7
18816622
J Clin Oncol. 2006 Mar 1;24(7):1072-8
16505426
Lancet Oncol. 2008 Jan;9(1):39-44
18077217
Oncology. 2007;72(1-2):105-10
18025804
J Clin Oncol. 2006 Oct 20;24(30):4914-21
17050875
J Clin Oncol. 2005 May 20;23(15):3568-76
15809453
Gynecol Oncol. 2008 Mar;108(3):493-9
18191993
J Clin Oncol. 2006 Jun 20;24(18):2866-72
16717293
Ann Oncol. 2008 Feb;19(2):362-9
17947225
J Clin Oncol. 2006 Nov 20;24(33):5253-8
17114658
J Clin Invest. 2007 Aug;117(8):2051-8
17671639
Radiographics. 2000 Jan-Feb;20(1):83-98
10682774
Cancer. 2007 Aug 1;110(3):581-9
17583545
J Thorac Oncol. 2008 Jun;3(6):648-51
18520806
Ann Oncol. 2008 Jul;19(7):1288-1292
18349029
J Heart Lung Transplant. 2007 Dec;26(12):1340-4
18096489
Clin Breast Cancer. 2006 Aug;7(3):270-7
16942645
J Clin Oncol. 2000 Feb;18(4):904-14
10673534
Lung Cancer. 2010 Jan;67(1):86-92
19380175
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1081-6
17881150
N Engl J Med. 2004 Jul 22;351(4):337-45
15269313
J Clin Oncol. 2007 Nov 20;25(33):5225-32
18024868
Anticancer Res. 2008 Jul-Aug;28(4C):2459-67
18751435
Br J Cancer. 2006 Mar 27;94(6):792-7
16508634
J Clin Oncol. 2007 Dec 20;25(36):5777-84
18089875
N Engl J Med. 2006 Feb 9;354(6):567-78
16467544
Lancet. 2009 May 2;373(9674):1525-31
19410716
Clin Colorectal Cancer. 2006 Mar;5(6):422-8
16635281